Financial News
Latest News about NVAX
Recent news which mentions NVAX
NVAX Stock Alert: What Is Going on With Novavax Today?
December 31, 2021
Tickers
NVAX
From InvestorPlace
It's Not Too Late to Add These 5 No-Brainer Stocks to Your IRA in 2021
December 31, 2021
From Motley Fool
Novavax is In Position to Move Upward While Awaiting More Good News
December 30, 2021
Tickers
NVAX
From InvestorPlace
This Industry Grew During Covid, Against All Odds: Here's Why You Should Consider Investing
December 30, 2021
From Benzinga
From Motley Fool
25 Stocks Moving In Tuesday's Mid-Day Session
December 28, 2021
From Benzinga
Why Novavax Stock Is Jumping Today
December 28, 2021
From Motley Fool
51 Biggest Movers From Yesterday
December 28, 2021
From Benzinga
Novavax Falls Below Support: What Does This Mean For The Vaccine Stock?
December 27, 2021
Tickers
NVAX
From Benzinga
NVAX Stock Dips Ahead of Potential Novavax Catalyst. What to Know.
December 27, 2021
Tickers
NVAX
From InvestorPlace
34 Stocks Moving In Monday's Mid-Day Session
December 27, 2021
From Benzinga
January will be a huge month for these hard-hit stocks. Why now’s the time to load up on riskier names, says JPMorgan.
December 27, 2021
From MarketWatch
4 New Stocks I'll Likely Add to My Portfolio in 2022
December 26, 2021
From Motley Fool
Novavax Stock: Bull vs. Bear
December 24, 2021
From Motley Fool
3 COVID Stocks to Fight Omicron
December 23, 2021
From Motley Fool
KTTA Stock Alert: 6 Things to Know About Pasithea Therapeutics as Shares Soar Today
December 23, 2021
From InvestorPlace
From InvestorPlace
NVAX Stock: 5 Things to Know About Novavax’s Omicron-Fighting News
December 23, 2021
Tickers
NVAX
From InvestorPlace
FDA adds Merck antiviral to COVID-19 tool kit for high-risk adults above 18, amid flurry of positive news on boosters
December 23, 2021
From MarketWatch
Tesla Leads Automobile Stocks to be Among Wednesday's Top Performers
December 23, 2021
From Benzinga
Oil edges higher after ending at nearly 1-month high
December 23, 2021
From MarketWatch
The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
December 23, 2021
From Benzinga
These wild market forecasts have a 50% chance of happening in 2022, says hedge-fund investor
December 23, 2021
From MarketWatch
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.